BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2873 related articles for article (PubMed ID: 16111831)

  • 1. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
    Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
    Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
    Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice.
    Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW
    Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
    Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 144.